| A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes RM Neve, K Chin, J Fridlyand, J Yeh, FL Baehner, T Fevr, L Clark, ... Cancer cell 10 (6), 515-527, 2006 | 3736 | 2006 |
| RESPONSE: Re: Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine V Stearns, MD Johnson, JM Rae, A Novielli, P Bhargava, DF Hayes, ... Journal of the National Cancer Institute 96 (11), 884-885, 2004 | 1034* | 2004 |
| Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine V Stearns, MD Johnson, JM Rae, A Morocho, A Novielli, P Bhargava, ... Journal of the National Cancer Institute 95 (23), 1758-1764, 2003 | 1034 | 2003 |
| Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome LE Kuo, JB Kitlinska, JU Tilan, L Li, SB Baker, MD Johnson, EW Lee, ... Nature medicine 13 (7), 803-811, 2007 | 848 | 2007 |
| Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland MD Johnson, N Kenney, A Stoica, L Hilakivi-Clarke, B Singh, G Chepko, ... Nature medicine 9 (8), 1081-1084, 2003 | 711 | 2003 |
| Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen MD Johnson, H Zuo, KH Lee, JP Trebley, JM Rae, RV Weatherman, ... Breast cancer research and treatment 85 (2), 151-159, 2004 | 574 | 2004 |
| Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. AJ Stewart, MD Johnson, FE May, BR Westley Journal of Biological Chemistry 265 (34), 21172-21178, 1990 | 458 | 1990 |
| 8. WESTLEY, BR 1990. Role of insulin-like growth factors and the type l insulin-like growth factor receptor in the estrogenstimulated proliferation of human breast cancer cells AJ Stewart, MD JOHNSON, FE MAY J Biol Chem 265, 21172-8, 0 | 458* | |
| MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma research JM Rae, CJ Creighton, JM Meck, BR Haddad, MD Johnson Breast cancer research and treatment 104 (1), 13-19, 2007 | 442 | 2007 |
| Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays JM Rae, MD Johnson, ME Lippman, DA Flockhart Journal of Pharmacology and Experimental Therapeutics 299 (3), 849-857, 2001 | 411 | 2001 |
| Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk CY Lin, J Anders, M Johnson, RB Dickson Journal of Biological Chemistry 274 (26), 18237-18242, 1999 | 323 | 1999 |
| GREB1 is a critical regulator of hormone dependent breast cancer growth JM Rae, MD Johnson, JO Scheys, KE Cordero, JM Larios, ME Lippman Breast cancer research and treatment 92 (2), 141-149, 2005 | 306 | 2005 |
| Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. S Wojtowicz-Praga, J Torri, M Johnson, V Steen, J Marshall, E Ness, ... Journal of Clinical Oncology 16 (6), 2150-2156, 1998 | 301 | 1998 |
| Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity CY Lin, J Anders, M Johnson, QA Sang, RB Dickson Journal of Biological Chemistry 274 (26), 18231-18236, 1999 | 286 | 1999 |
| Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters MD Oberst, MD Johnson, RB Dickson, CY Lin, B Singh, M Stewart, ... Clinical cancer research 8 (4), 1101-1107, 2002 | 244 | 2002 |
| Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo M Oberst, J Anders, B Xie, B Singh, M Ossandon, M Johnson, RB Dickson, ... The American journal of pathology 158 (4), 1301-1311, 2001 | 238 | 2001 |
| The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor MD Oberst, CA Williams, RB Dickson, MD Johnson, CY Lin Journal of Biological Chemistry 278 (29), 26773-26779, 2003 | 233 | 2003 |
| TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate … YW Chen, MS Lee, A Lucht, FP Chou, W Huang, TC Havighurst, KM Kim, ... The American journal of pathology 176 (6), 2986-2996, 2010 | 205 | 2010 |
| Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco MD Johnson, J Schilz, MV Djordjevic, JR Rice, PG Shields Cancer Epidemiology and Prevention Biomarkers 18 (12), 3263-3304, 2009 | 202 | 2009 |
| p21CIP1 attenuates Ras-and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo M Liu, MC Casimiro, C Wang, LA Shirley, X Jiao, S Katiyar, X Ju, Z Li, ... Proceedings of the National Academy of Sciences 106 (45), 19035-19039, 2009 | 198 | 2009 |
James M RaeUniversity of MichiganVerified email at umich.edu
